Présentation orale d’abrégés

Cliquer sur le numéro de programme pour consulter les résumés.

Sciences Fondamentales

BS2.01	Characterization of HIV Reservoirs in Multiple Tissues Collected Post-mortem from Two Individuals on Suppressive ART
BS2.02	Pulmonary mucosal double negative T cells as HIV reservoirs during long-term ART
BS2.03	Plasma CXCL13 Correlates with Reservoir Size in Long-term ART-treated People Living With HIV
BS2.05	Hiv-1 Nef Enhances Viral Reactivation from Latency by Stimulating TNF-α Expression
BS3.01	Productively-Infected Cd4 T Cells are Resistant to Non-neutralizing Antibodies
BS3.02	Latency Reversing Agents: impact on Human Macrophages Susceptibility to HIV-1 Infection and Viral Production
BS3.05	Frequencies and Correlates of Endocervical Regulatory T Cells (Treg) Amongst HIV Seronegative Female Sex Workers (FSWs) in Nairobi
BS4.01	Nef Inhibitors as Adjuvants Towards a Cure for HIV/AIDS
BS4.02	Dynamics of regulatory and effector CD8 T-cells in mesenteric lymph nodes and blood during SIV infection of Rhesus Macaques and following early ART initiation
BS4.03	Impact of Early Antiretroviral Therapy on B and CD4 T Cell Dynamics in Lymphoid Tissues of SIV Infected Rhesus Macaques

Sciences Cliniques

CS1.01	Neurodevelopmental and Mental Health Co-morbidities in Canadian Children and Adolescents Living with HIV in the EPIC4 cohort
CS1.02	Double Trouble: Increased Risk of Congenital Cytomegalovirus Infection Among HIV-exposed Newborns
CS1.05	Reproductive Toxicity Studies to Evaluate Potential Neural Tube and Other Abnormalities Associated with Dolutegravir Exposure in Pregnancy
CS3.02	Effect of Metformin Treatment on Non-Diabetic HIV-Infected Individuals on ART
CS3.03	Declining Prevalence of Drug Interactions Between Antiretroviral and Other Drugs in Antiretroviral Therapy (ART)-Treated Persons in British Columbia (BC), 2010-2016
CS3.04	Untimed Plasma Efavirenz Levels after Switching from Brand to Generic Formulations
CS3.05	Utility of HIV Drug Resistance Testing in Low Viral Load Samples
CS4.01	Effectiveness of an Intervention to Reengage HIV-Positive Patients Into Care (Lost & Found)
CS4.02	Syndemic Effects of Childhood Adverse Experiences, Depression, and Substance Use on Antiretroviral Non-adherence among Participants of the OHTN Cohort Study

Épidémiologie et Siences de la Santé Publique

EPH1.01	Using Administrative Pharmaceutical Prescription Data to Estimate the Number of Persons on HIV Antiretroviral Treatment, Canada, 2014–2018
EPH1.02	A Novel Phylogenetic Approach to Prioritizing HIV-1 Transmission Clusters
EPH1.03	Using Population-level Latent Class Analysis to Classify People Living with HCV in British Columbia (BC) for Targeted Program Planning
EPH1.05	Hepatitis C Virus (HCV) Treatment, Injection Practices, and Access to Harm Reduction among HIV-HCV co-infected People who Inject Drugs in Montréal from 2003-2018
EPH2.02	Depression is associated with bacterial sexually transmitted infections (STIs) among gay, bisexual, and other men who have sex with men (gbMSM)
EPH2.07	Scale-up and Sustainability of Digital Public Health Services for STBBI Testing: an Investigation of Healthcare Service and HIV Policy Context in British Columbia
EPH3.02	Sporadic Clustered Outbreaks of HIV Among MSM Persist in Treatment-as-Prevention Era
EPH3.03	Short-Term Impacts of the Phénix Program: a Promising Community-Based Intervention to Improve gbMSM’s Sexual Health and Wellbeing
EPH4.02	PrEP uptake amongst MSM accessing sexual health services in Ontario and British Columbia – Results of the PrIMP Community Survey
EPH4.05	Uptake of PrEP among Users of Non-occupational PEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montréal (2013 – 2019)

SS1.02	Recent developments in Canada’s approach to HIV criminalization : The role of the Canadian Coalition to Reform HIV Criminalization in fostering change
SS2.01	“People Give and Take a Lot in Order to Participate in Things:” Making a Case for Non-participation in HIV CBPR and Participatory Programming with Young People
SS3.02	Making “Risk” Visible in Perinatal Care for Mothers Living with HIV in Ontario: An Institutional Ethnography
SS3.06	Social Support and STBBI Transmission Behaviours Among HIV-Negative Gay, Bisexual, and Other Men Who Have Sex with Men (GBM)
SS4.04	Peer Health Advocacy Wellness Network (PHAWN): Commencing a Network of Peers within First Nations Communities in Saskatchewan
SSKP1.02	Barriers to access to antiretroviral treatment and care for people living with HIV with precarious immigration status
SSKP1.03	Celebrate: Love, Laugh & Live Together (Celebrate: 3LT). an Inter-generational Exploration of Grief and Loss Through Story-making
SSKP4.02	How Does HIV Optimism Feature Within the Perspectives and Experiences of Young Sexual and Gender Minority Men? A Discourse Analysis
SSKP4.06	The role of perceived discrimination on suicidal ideation among gay, bisexual and other men who have sex with men in Montreal

Populations Clés

KP1.01	Successes and Challenges in Empowerment Strategies amongst Newcomer PHAs: Insights from the Ethno-racial Treatment Support Network Training Evaluation Study
KP2.03	Tracks Survey of people who inject drugs in Canada, Phase 4 2017-2019 – Selected findings among Indigenous participants
KP2.04	Culturally Specific and Gender Based STBBI Interventions Designed by and for Incarcerated Indigenous Women
KP3.01	“I felt safe there”: Implications of an Acute Care Supervised Consumption Service for the Hospital Risk Environment
KP3.02	HIV and HCV Cascade of Care Among People Who Inject Drugs in the SurvUDI Network – 2003 to 2017
KP4.01	Preliminary results of the Dual Daily HIV and Syphilis Pre-Exposure Prophylaxis (DuDHS) Trial.